Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies

Immunoproliferative Disorders trial results

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Weill Cornell Univ Hospitals New York, United States
View all 14 locations
Conditions
Carcinoma, Carcinoma, Squamous Cell, Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, +13 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Providence St. John's Health Center Santa Monica, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 24 locations
Conditions
Adnexal Diseases, Astrocytoma, B-cell Malignancies, +53 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • UCSF - University of California San Francisco San Francisco, California, United States
View all 24 locations
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Carle Cancer Center Urbana, Illinois, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • St. Joseph Mercy Hospital Cancer Care Center Ann Arbor, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States